David M. Stack's most recent trade in Pacira BioSciences Inc was a trade of 245,400 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 14, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 245,400 | 245,400 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 32,700 | 186,481 (0%) | 0% | 0 | Common Stock | |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 37.87 per share. | 06 Jun 2023 | 5,326 | 153,781 (0%) | 0% | 37.9 | 201,669 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 38.99 per share. | 06 Jun 2023 | 5,058 | 159,107 (0%) | 0% | 39.0 | 197,216 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 160,900 | 160,900 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 21,500 | 163,751 (0%) | 0% | 0 | Common Stock | |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 61.37 per share. | 06 Jun 2022 | 11,965 | 156,079 (0%) | 0% | 61.4 | 734,340 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 59.10 per share. | 06 Jun 2022 | 7,039 | 149,040 (0%) | 0% | 59.1 | 416,005 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 60.33 per share. | 06 Jun 2022 | 5,006 | 144,034 (0%) | 0% | 60.3 | 302,012 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 61.31 per share. | 06 Jun 2022 | 1,282 | 142,752 (0%) | 0% | 61.3 | 78,599 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 61.96 per share. | 06 Jun 2022 | 501 | 142,251 (0%) | 0% | 62.0 | 31,042 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2022 | 22,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.81 per share. | 28 Apr 2022 | 22,500 | 168,044 (0%) | 0% | 10.8 | 243,225 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.81 per share. | 31 Mar 2022 | 22,500 | 145,544 (0%) | 0% | 10.8 | 243,225 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2022 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.81 per share. | 25 Jan 2022 | 13,670 | 123,044 (0%) | 0% | 10.8 | 147,773 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2022 | 13,670 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.81 per share. | 11 Jan 2022 | 15,000 | 109,374 (0%) | 0% | 10.8 | 162,150 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jan 2022 | 15,000 | 58,670 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.81 per share. | 16 Nov 2021 | 15,000 | 94,085 (0%) | 0% | 10.8 | 162,150 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2021 | 15,000 | 73,670 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 61.04 per share. | 04 Jun 2021 | 14,905 | 61,156 (0%) | 0% | 61.0 | 909,756 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Mar 2021 | 21,250 | 109,920 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Mar 2021 | 21,250 | 88,670 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.81 per share. | 24 Mar 2021 | 21,250 | 97,311 (0%) | 0% | 10.8 | 229,713 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.81 per share. | 24 Mar 2021 | 21,250 | 97,311 (0%) | 0% | 10.8 | 229,713 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 62.08 per share. | 24 Mar 2021 | 14,669 | 79,672 (0%) | 0% | 62.1 | 910,652 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 60.78 per share. | 24 Mar 2021 | 13,318 | 83,993 (0%) | 0% | 60.8 | 809,468 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 61.19 per share. | 24 Mar 2021 | 7,932 | 76,061 (0%) | 0% | 61.2 | 485,359 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 62.41 per share. | 24 Mar 2021 | 3,611 | 76,061 (0%) | 0% | 62.4 | 225,363 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 60.76 per share. | 24 Mar 2021 | 2,970 | 94,341 (0%) | 0% | 60.8 | 180,457 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Mar 2021 | 1,080 | 97,273 (0%) | 0% | 0 | Common Stock | |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.81 per share. | 02 Feb 2021 | 21,250 | 97,311 (0%) | 0% | 10.8 | 229,713 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2021 | 21,250 | 131,170 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2021 | 21,250 | 152,420 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.81 per share. | 02 Feb 2021 | 21,250 | 97,311 (0%) | 0% | 10.8 | 229,713 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 71.42 per share. | 02 Feb 2021 | 14,350 | 76,061 (0%) | 0% | 71.4 | 1,024,877 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 69.38 per share. | 02 Feb 2021 | 14,250 | 80,161 (0%) | 0% | 69.4 | 988,665 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 70.78 per share. | 02 Feb 2021 | 6,900 | 90,411 (0%) | 0% | 70.8 | 488,382 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 70.20 per share. | 02 Feb 2021 | 4,100 | 76,061 (0%) | 0% | 70.2 | 287,820 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 68.41 per share. | 02 Feb 2021 | 2,900 | 94,411 (0%) | 0% | 68.4 | 198,389 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 55.53 per share. | 14 Oct 2020 | 30,000 | 173,377 (0%) | 0% | 55.5 | 1,665,900 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Oct 2020 | 30,000 | 173,670 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Oct 2020 | 30,000 | 203,670 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Oct 2020 | 30,000 | 233,670 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 55.56 per share. | 14 Oct 2020 | 30,000 | 173,377 (0%) | 0% | 55.6 | 1,666,800 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.81 per share. | 14 Oct 2020 | 30,000 | 203,377 (0%) | 0% | 10.8 | 324,300 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 55.00 per share. | 14 Oct 2020 | 30,000 | 173,377 (0%) | 0% | 55 | 1,650,000 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.81 per share. | 14 Oct 2020 | 30,000 | 203,377 (0%) | 0% | 10.8 | 324,300 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.81 per share. | 14 Oct 2020 | 30,000 | 203,377 (0%) | 0% | 10.8 | 324,300 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 61.79 per share. | 17 Aug 2020 | 11,783 | 176,594 (0%) | 0% | 61.8 | 728,072 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 62.34 per share. | 17 Aug 2020 | 3,217 | 173,377 (0%) | 0% | 62.3 | 200,548 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 56.88 per share. | 15 Jul 2020 | 12,000 | 188,377 (0%) | 0% | 56.9 | 682,560 | Common Stock |